News
Vutrisiran can improve and maintain functional capacity and quality of life in patients with transthyretin amyloidosis with ...
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
LOS ANGELES, April 23, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL ...
Medical testing laboratory Dr. Lal PathLabs said on Tuesday that it has become south Asia’s first diagnostic chain to offer ...
A patient was found to have suffered an “unnecessary delay” in treatment for their heart condition before their death. The ...
Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis ...
Dr Lal Pathlabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry a breakthrough test for accurately identifying different types of Amyloid proteins. With this launch, ...
The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...
19h
News Medical on MSNNew recommendations for the treatment of familial Mediterranean feverEULAR - The European Alliance of Associations for Rheumatology - published recommendations on the treatment of familial Mediterranean fever (FMF). Since then, new evidence has become available, so the ...
Samples can be collected from anywhere in India and sent to the National Reference Lab, Rohini, New Delhi, for testing ...
When Rosaline Callaghan hit her early 50s, she feared she was a ticking timebomb and it was only a matter of years before she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results